BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 296 filers reported holding BLUEBIRD BIO INC in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $17,243,000 | -19.8% | 398,494 | 0.0% | 0.04% | -29.7% |
| Q3 2020 | $21,499,000 | +8.1% | 398,494 | +22.3% | 0.06% | +1.6% |
| Q2 2020 | $19,888,000 | +32.8% | 325,821 | 0.0% | 0.06% | +5.0% |
| Q1 2020 | $14,975,000 | -47.6% | 325,821 | 0.0% | 0.06% | -35.5% |
| Q4 2019 | $28,591,000 | +10.7% | 325,821 | +15.9% | 0.09% | +1.1% |
| Q3 2019 | $25,822,000 | +41.7% | 281,220 | +96.3% | 0.09% | +50.8% |
| Q2 2019 | $18,227,000 | +364440.0% | 143,291 | +477536.7% | 0.06% | – |
| Q1 2019 | $5,000 | – | 30 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6,335,528 | $40,104,000 | 4.92% |
| qPULA Trading Management LP | 14,344 | $91,000 | 0.80% |
| Frazier Life Sciences Management, L.P. | 1,440,757 | $9,120,000 | 0.70% |
| Ikarian Capital, LLC | 462,628 | $2,928,000 | 0.58% |
| Birchview Capital, LP | 98,000 | $620,000 | 0.44% |
| HealthCor Management, L.P. | 455,000 | $2,880,000 | 0.36% |
| Financial Advocates Investment Management | 45,071 | $3,538,000 | 0.29% |
| PDT Partners, LLC | 262,767 | $1,663,000 | 0.25% |
| Monaco Asset Management SAM | 80,000 | $506,000 | 0.19% |
| Summit X, LLC | 103,424 | $651,000 | 0.19% |